Showing results (91-100 of 166) with videos related to
Sort By:
Pageof 17
Annals of Neurology|January 13, 2018
Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout diseaseChristina J Azevedo, Steven Y Cen, Sankalpa Khadka, et al.Neurology|July 13, 2012
A randomized trial of stress management for the prevention of new brain lesions in MSDavid C Mohr, Jesus Lovera, Ted Brown, et al.Neurology|November 16, 2018
Body mass index, but not vitamin D status, is associated with brain volume change in MSEllen M Mowry, Christina J Azevedo, Charles E McCulloch, et al.Archives of Neurology|August 12, 2009
Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adultsEmmanuelle Waubant, Dorothee Chabas, Darin T Okuda, et al.JAMA Neurology|May 21, 2014
Magnetic resonance spectroscopy markers of disease progression in multiple sclerosisSara Llufriu, John Kornak, Helene Ratiney, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Cerebellar volume loss in radiologically isolated syndromeIlena C George, Mohamed Mounir El Mendili, Matilde Inglese, et al.Journal of the Neurological Sciences|August 20, 2016
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disordersChristine Lebrun, Mikael Cohen, Beatrice Pignolet, et al.Annals of Neurology|July 22, 2014
In vivo evidence of glutamate toxicity in multiple sclerosisChristina J Azevedo, John Kornak, Philip Chu, et al.Human Brain Mapping|August 1, 2012
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modelingStefan M Gold, Mary-Frances O'Connor, Raja Gill, et al.Brain : a Journal of Neurology|August 31, 2010
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosisSergio E Baranzini, Radhika Srinivasan, Pouya Khankhanian, et al.Pageof 17